VCYT Insider Activity: 9,321-Share RSU Grant to Director Eliav Barr

Rhea-AI Filing Summary

Form 4 filing for Veracyte, Inc. (VCYT) discloses that director Eliav Barr received 9,321 restricted stock units (RSUs) on 18-Jun-2025. The grant price is shown as $0 because RSUs are awarded, not purchased. After the award, Barr’s direct ownership rises to 51,189 common shares.

The RSUs vest 100 % on the first anniversary of the grant or immediately before the next annual shareholder meeting, whichever occurs first. Full vesting also accelerates upon a change-in-control event. No derivative transactions were reported, and no sales occurred.

This filing signals routine board compensation rather than an open-market purchase. While it incrementally increases insider alignment with shareholders, the share count is small and has minimal dilution impact for Veracyte’s ~72 million outstanding shares (figure not in filing). Investors typically view RSU awards as neutral to slightly positive, given the absence of cash outlay and the long-term incentive structure.

Positive

• Increased insider ownership: Director Eliav Barr’s holdings rise to 51,189 shares, marginally aligning interests with shareholders.
• Standard long-term incentive structure: One-year vesting encourages board continuity and shareholder-value focus.

Negative

• Minor dilution: Issuance of 9,321 new shares, while small, slightly expands share count.
• No open-market buying signal: Grant reflects compensation rather than discretionary insider purchase, limiting bullish interpretation.

Insights

Equity Compensation Analyst

TL;DR: Routine RSU grant to director; minor dilution, modest alignment, negligible market impact.

The 9,321-share RSU award increases Barr’s stake but represents <0.01 % of total shares outstanding. Because there is no cash purchase, it does not convey incremental bullish conviction beyond accepting board equity. Vesting terms are standard and include a change-in-control accelerator, common in peer group governance structures. Overall impact on valuation, EPS, and float is immaterial; therefore, the filing is primarily administrative.

Insider Trade Summary

Net Buyer: 9,321 shares

Net Buy 1 txn

Insider Barr Eliav

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,321	$0.00	$0.00

Holdings After Transaction: Common Stock — 51,189 shares (Direct)

Footnotes (1)

1. F1. Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/23/2025 - 04:09 PM Learn about SEC filing dates

FAQ

How many Veracyte (VCYT) shares did director Eliav Barr receive?

He was awarded 9,321 restricted stock units on 18-Jun-2025.

Does the filing indicate any insider selling of VCYT shares?

No. The Form 4 shows only an RSU award and no share disposals.

When do the RSUs granted to Eliav Barr vest?

They vest in full on the first anniversary of the grant or immediately before the next annual shareholder meeting, whichever is earlier.

Will the RSUs accelerate upon a change in control of Veracyte?

Yes. The RSUs vest completely if a change-in-control event occurs.

What is Eliav Barr’s total Veracyte share ownership after this transaction?

Following the award, Barr directly owns 51,189 shares of VCYT common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barr Eliav

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A(1)		9,321	A	$0	51,189	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.